The Role of Remote Glucose Management Using Real-time Continuous Glucose Monitoring Systems in ICU-hospitalized Patients with COVID-19

The recent coronavirus disease 2019 (COVID-19) pandemic has induced many challenges in the clinical environment worldwide. In a bid to reduce the exposure of healthcare providers to severe acute respiratory syndrome coronavirus 2 and the utilization of personal protective equipment (PPE), while maintaining optimal patient care, in April 2020, the US Food and Drug Administration issued a new policy, allowing the use of continuous glucose monitoring (CGM) systems in the intensive care unit (ICU) setting. This article aimed to explore the role of real-time continuous glucose monitoring systems in patients in the ICU with COVID-19. The hybrid protocols integrating real-time CGM and point of care seem to be a feasible and safe alternative for the glycaemic management of critically ill patients with COVID-1 9, including the reduction of healthcare providers’ exposure and the preservation of PPE, whilst achieving and maintaining optimal glycaemic control.

• Publication year

  2025

• Venue

  touchREVIEWS in Endocrinology

• Publication date

  2025-04-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.17925/EE.2025.21.1.7PMID 40485649PMCID 12140640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Real-time Continuous Glucose Monitoring in the Intensive Care Unit: The Fifth Vital Sign.

  2024cited by this paper
• Continuous Glucose Monitoring in the Intensive Care Unit

  2023cited by this paper
• Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU

  2021influential reference
• Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study.

  2021influential reference
• Use and Accuracy of Inpatient CGM During the COVID-19 Pandemic: An Observational Study of General Medicine and ICU Patients

  2021influential reference
• Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept

  2021influential reference
• Diabetes and COVID-19

  2020cited by this paper
• Diabetes is a risk factor for the progression and prognosis of COVID‐19

  2020cited by this paper
• Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic

  2020cited by this paper
• Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

  2020cited by this paper
• Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports

  2020cited by this paper
• Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

  2020cited by this paper
• Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic

  2020cited by this paper
• A Pilot Study of the Feasibility and Accuracy of Inpatient Continuous Glucose Monitoring

  2020cited by this paper
• Performance of a factory-calibrated, real-time continuous glucose monitoring system during elective abdominal surgery.

  2020cited by this paper
• Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic

  2020cited by this paper
• Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience

  2020cited by this paper
• Managing Hyperglycemia in the COVID-19 Inflammatory Storm

  2020cited by this paper
• Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study

  2020influential reference
• COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes

  2020cited by this paper
• Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis

  2020cited by this paper
• Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic

  2020influential reference
• Center for Devices and Radiological Health

  2020cited by this paper
• Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis

  2020cited by this paper
• Prevalence and impact of diabetes among people infected with SARS-CoV-2

  2020cited by this paper
• Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems

  2019cited by this paper
• Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

  2018cited by this paper
• Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices

  2018influential reference
• Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach

  2018cited by this paper
• Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial

  2017cited by this paper
• Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor

  2017cited by this paper
• Continuous glucose monitoring in the ICU: clinical considerations and consensus

  2017cited by this paper
• Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.

  2017cited by this paper
• Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial

  2016cited by this paper
• Clinical Accuracy of a Continuous Glucose Monitoring System With an Advanced Algorithm

  2014cited by this paper
• Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel.

  2013cited by this paper
• An Analysis of “No Effect of Insulin Pen with Memory Function on Glycemic Control in a Patient Cohort with Poorly Controlled Type 1 Diabetes: A Randomized Open-Label Study”

  2012cited by this paper
• Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline.

  2012cited by this paper
• Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.

  2009cited by this paper
• Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition.

  2005cited by this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cited by this paper

• No citing papers are available for this paper.